Apoptotic response to oncogenic stimuli: Cooperative and antagonistic interactions between c-myb and the growth suppressor p53

Cancer Research

Volumn 56, Issue 9, 1996, Pages 1991-1996

  Sala, Arturo ^a   Casella, Ida ^a   Grasso, Luigi ^a   Bellon, Teresa ^a   Reed, John C ^c   Miyashita, Toshiyuki ^c,d   Peschle, Cesare ^a,b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c BURNHAM INSTITUTE   (United States)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYB; OSTEOSARCOMA; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN DNA BINDING; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, NORTHERN; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENES, P53; HUMANS; MICE; ONCOGENES; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; S PHASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029996277     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gewirtz, A M., and Calabretta, B A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science (Washington DC), 242: 1303-1306, 1988.
2. Clarke, M F., Kukowska-Latallo, J. F., Westin, E., Smith, M., and Prochownick, E. V. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell. Biol., 8: 884-892, 1988.
3. Mucenski, M. L., McLain A., Kier, A. B , Swerdlow, S. H., Schreiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J., and Potter, S. S. A functional c-myb gene is required for normal murine fetal hematopoiesis. Cell, 65: 677-689, 1991.
4. Sakura, H , Kanei-Ishu, C , Nagase, T , Nakagoshi, H , Gonda, T. J., and Ishii, S Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci. USA, 86. 5758-5762, 1989
5. Weston, K., and Bishop, J. M Transcriptional activation by the v-myb oncogene and its cellular progenitor c-myb Cell, 58: 85-93, 1989
6. Ness, S. A , Marknell, A., and Graf, T. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell. 59: 1115-1125, 1989.
7. Sala, A., Bellon, T., Melotti, P., Peschle, C., and Calabretta, B. Inhibition of erythromyeloid differentiation by constitutive expression of a DNA binding-deficient mutant: implication for c-myb function. Blood, 86: 3404-3412, 1995.
8. Engelke, U , Whittaker, L., and Lipsick, J. S. Weak transcriptional activation is sufficient for transformation by v-myb. Virology, 208 467-477, 1995.
9. Dini, P W., and Lipsick, J. S. Oncogenic truncation of the first repeat of c-myb decreases DNA binding in vitro and in vivo Mol. Cell Biol. 13: 7334-7348, 1993
10. Foos, G , Natour, S., and Klempnauer, K. H TATA-box dependent transactivation of the human HSP70 promoter by myb proteins. Oncogene, 8. 1775-1782, 1993
11. Selvakumaran, M , Lin, H. K , Sjin, R. T., Reed, J. C. Liebermann, D. A., and Hoffman, B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol., 14: 2352-2360, 1994.
12. Oltvai, Z. N., Milliman, C L., and Korsmeyer, S J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74. 609-619, 1993.
13. Miyashita, T., and Reed, J. C Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80: 293-299, 1995.
14. Soddu, S , Blandino, G., Scardigli., R., Martinelli, R., Rizzo, M. G., Crescenzi, M., and Sacchi, A Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol., 16. 487-495, 1996.
15. El-Deiry, W. S., Tokino, T., Velculescu, V E , Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E , Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
16. Sala, A., and Calabretta, B. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc Natl. Acad. Sci. USA, 89 10415-10419, 1992.
17. Chomczynski, P., and Sacchi, N Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162. 156-161, 1987.
18. Zhu, L , van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., and Harlow, E Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein Genes Dev., 7: 1111-1125, 1993.
19. Nicolaides, N. C., Gualdi, R , Casadevall, C., Manzella, L., and Calabretta, B. Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene. Mol. Cell. Biol., 11. 6166-6176, 1991
20. Sehgal, P. B., and Margulies, L. Cell-type- and promoter-dependent ts phenotype of p53 Va1135 Oncogene, 8: 3417-3419, 1993.
21. Yonish-Rouach, E., Deguin, V., Zaitchouk, T. Breugnot, C., Mishal, Z., Jenkins, J. R., and May, E. Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53 Oncogene, 12: 2197-2205, 1996.
22. Vorbrueggen, G , Kalkbrenner, F., Guehmann, S., and Moelling, K. The carboxy terminus of human c-myb protein stimulates activated transcription in trans. Nucleic Acids Res., 22: 2466-2475, 1994.
23. Favier, D and Gonda, T. J. Detection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene, 9: 305-311, 1994.
24. Berger, S. L., Pina, B , Silverman, N , Marcus, G. A., Agapite, J., Regier, J. L., Triezenberg, S. J , and Guarente L. Genetic isolation of ADA2: a potential transcriptional adaptor required for function of certain acidic activation domains. Cell, 70. 251-256, 1992.